Pale Fire Capital SE invested $28,000 in Design Therapeutics (NASDAQ:DSGN) and increased holdings in Compass Therapeutics (NASDAQ:CMPX).
Pale Fire Capital SE invested $28,000 in Design Therapeutics (NASDAQ:DSGN) during the 4th quarter, purchasing 10,500 shares. Other institutional investors also increased their holdings in DSGN, including Jump Financial LLC (284.7% increase) and Barclays PLC (353.1% increase). Pale Fire Capital also boosted its holdings in Compass Therapeutics (NASDAQ:CMPX) by 301.0%, owning 181,055 shares valued at $282,000 as of its latest SEC filing.
June 09, 2024
3 Articles